Stephen Shuttleworth
InvestorVenture Partner at Samsara BioCapital
Bourne End, England, United Kingdom
Find your path to Stephen
258 people in our graph can introduce you to Stephen.
Each arrow is one introduction. Sign up to fill in the first one.
Ask Magdalena Jonikas to introduce you to Stephen
You →Magdalena · together at Mosaic Tx (2025–2026) →Stephen
Ask Jamie Chen to introduce you to Stephen
You →Jamie · 6 people · together at Cancerresearchuk →Stephen
Ask Sam Okafor to introduce you to Stephen
You →Sam · 2 people · together at Samsara Biocapital →Stephen
Sign up to find every way you can get introduced to Stephen
- Your email: the people you already email who know Stephen
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with Stephen
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
About
Venture Partner since 2019, a pharmaceutical scientist with over 30 years in the biotech industry. He was CSO and joint COO/CSO of Karus Therapeutics and directed small molecule oncology programs including the pan-PI3K agent Pictilisib at Piramed; he holds a PhD in Chemistry from the University of Liverpool.
Experience
- Samsara BioCapitalVenture Partnercurrent2019 — presentPalo Alto, California, United States
- Oxford Science EnterprisesConsultantcurrent2026 — present
- Wharf Biotech Consulting Ltd.Directorcurrent2021 — presentBourne End, England, United Kingdom
- Mosaic TXCSO2025 — 2026Cambridge
- Autobahn Labs, Inc.Scientific Advisor2019 — 2025Palo Alto, California, United States
- Nalo Therapeutics, Inc.CTO2019 — 2024San Francisco Bay Area, United States
- Topspin Therapeutics Inc. (Now Integer Bio Inc.)CEO and Co-Founder2020 — 2022Palo Alto, California, United States
- Karus Therapeutics LimitedChair of The Scientific Advisory Board2019 — 2020Oxfordshire, UK
- Karus Therapeutics LimitedCSO, COO and Executive Director2017 — 2019Oxfordshire, UK
- Karus Therapeutics LimitedCSO and Executive Director2008 — 2017Oxfordshire, UK
- The University of ManchesterHonorary Professor, Molecular & Clinical Cancer Sciences, School of Medical Science2014 — 2020
- HOX Therapeutics LimitedNon Executive Director2019Thame, Oxfordshire, UK
- Cancer Research UKHead of New Projects Development2006 — 2008London, United Kingdom
- Piramed Ltd.Director of Chemistry2003 — 2006Slough, United Kingdom
- Tularik Inc.Associate Director, Chemistry2000 — 2003South San Francisco, California, USA
- Biochem Pharma Inc.Research Leader, Chemistry1997 — 2000Laval, Quebec, Canada
- Glycodesign Inc.Head of High Throughput Medicinal/Combinatorial Chemistry1997Toronto, Ontario, Canada
- Chiroscience Ltd.Senior Scientist and Head of Parallel Synthesis1994 — 1997Cambridge, United Kingdom
Skills & more
+6 more
OncologyPharmacologyR&DAnalytical ChemistryCRO ManagementDrug Design- Fellow of the Royal Society of Chemistry and Chartered Chemist — Royal Society of Chemistry
From Stephen's professional profile.
Colleagues at Samsara BioCapital
Frequently asked questions
- Who is Stephen Shuttleworth?
- Venture Partner since 2019, a pharmaceutical scientist with over 30 years in the biotech industry. He was CSO and joint COO/CSO of Karus Therapeutics and directed small molecule oncology programs including the pan-PI3K agent Pictilisib at Piramed; he holds a PhD in Chemistry from the University of Liverpool.
- Where does Stephen Shuttleworth work?
- Stephen Shuttleworth is Venture Partner at Samsara BioCapital.
- Where did Stephen Shuttleworth go to school?
- Stephen Shuttleworth studied at University of Liverpool (PhD, Organic Chemistry); University of Liverpool (BSc (Hons), Chemistry); St Edward's College, Liverpool.
Same school
Also attended University of Liverpool110
+ 104 more
Shared employers
Also worked at Mosaic TX1
Also worked at The University of Manchester32
+ 26 more
Also worked at Cancer Research UK35
+ 29 more






























